Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)
4.150
+0.010 (0.24%)
Feb 4, 2026, 10:15 AM CST
Guizhou Bailing Group Pharmaceutical Company Description
Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China.
It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines and honey.
Its products are used for cardiovascular, cough, cold, gynecological, and pediatric areas. The company was incorporated in 1999 and is headquartered in Anshun, China.
Guizhou Bailing Group Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1999 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6,586 |
| CEO | Min Niu |
Contact Details
Address: No. 212, Xihang Road Anshun, 561000 China | |
| Phone | 86 851 3341 5126 |
| Website | gzbl.com |
Stock Details
| Ticker Symbol | 002424 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000PY3 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Wei Jiang | Acting Secretary of the Board of Directors and Chairman |
| Min Niu | GM and Director |
| Hongxing Li | Chief Financial Officer |
| Pei Chen | Deputy GM and Director |
| Yuan Zhen Yuan | Executive Vice President |
| Yong Jiang | Director |
| Zhining Wu | Accounting Supervisor |